Funding helps build epidemiology and laboratory capacity Atlanta, GA–(ENEWSPF)–August 20, 2013. Today, the Centers for Disease Control and Prevention (CDC) announced an award to states of about $75.8 million through the Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement (ELC). This funding helps states and communities strengthen core epidemiology[Read More…]
Health and Fitness
Overdose Awareness Week Kicks Off at Roosevelt University’s Schaumburg Campus on Aug. 24
Above, a memorial graveyard of headstones remembering those who have died of overdoses in Illinois will be part of the event. Schaumburg, IL–(ENEWSPF)–August 20, 2013. On Saturday, Aug. 24, more than 300 people coming from throughout Chicagoland and the Midwest will kick off International Overdose Awareness week at Roosevelt[Read More…]
Endocannabinoids Trigger Inflammation That Leads to Diabetes
NIH scientists identify possible treatment target for type 2 diabetes Bethesda, Maryland–(ENEWSPF)–August 20, 2013. Researchers at the National Institutes of Health have clarified in rodent and test tube experiments the role that inflammation plays in type 2 diabetes, and revealed a possible molecular target for treating the disease. The researchers[Read More…]
State Judge Blocks Oklahoma Emergency Contraception Restrictions
Plan B One-Step can remain on pharmacy, grocery store shelves without restriction pending outcome of Center for Reproductive Rights lawsuit OKLAHOMA–(ENEWSPF)–August 20, 2013. A state judge ruled yesterday that an Oklahoma state law placing unnecessary barriers on women’s access to emergency contraception cannot take effect pending the outcome of a[Read More…]
Medical Marijuana Patient Advocates To Hold Statewide Illinois Conference on Implementation of Law
With the passage of HB1 earlier this month, key stakeholders will meet this Thursday to discuss next steps Chicago, IL–(ENEWSPF)–August 19, 2013. Medical marijuana advocates will hold a 4-hour conference this Thursday from 1pm-5pm to discuss implementation of HB1, the Illinois medical marijuana law that was signed by Governor Quinn[Read More…]
3-D Images Show Flame Retardants Can Mimic Estrogens in NIH Study
Bethesda, Maryland–(ENEWSPF)–August 19, 2013. By determining the three-dimensional structure of proteins at the atomic level, researchers at the National Institutes of Health have discovered how some commonly used flame retardants, called brominated flame retardants (BFRs), can mimic estrogen hormones and possibly disrupt the body’s endocrine system. BFRs are chemicals added[Read More…]
Latino Children at Risk of Delayed ASD Diagnosis
Elk Grove Village, IL—(ENEWSPF)—August 19, 2013. A study in the September 2013 issue of Pediatrics, “Pediatrician Identification of Latino Children at Risk for Autism Spectrum Disorder,” (published online Aug. 19) surveyed 267 California primary care pediatricians about identifying Latino children with autism spectrum disorder (ASD). Latino children are diagnosed with[Read More…]
CDC Provides Estimate of Americans Diagnosed With Lyme Disease Each Year
Atlanta, GA–(ENEWSPF)–August 19, 2013. Preliminary estimates released by the Centers for Disease Control and Prevention indicate that the number of Americans diagnosed with Lyme disease each year is around 300,000. The preliminary estimates were presented Sunday night in Boston at the 2013 International Conference on Lyme Borreliosis and Other Tick-Borne[Read More…]
Governor Chris Christie Eases Access to New Jersey’s Medical Marijuana Program for Sick Children
Calls for Lifting Three-Strain Cultivation Limit, Allowing Edible Consumption for Children and Giving Parents Choice Trenton, NJ–(ENEWSPF)–August 16, 2013. Acting with the belief that parents, and not government regulators, are best suited to decide how to care for their children, Governor Chris Christie today acted to ease access for sick[Read More…]
Pretreating Aggressive Lymphoma with Targeted Therapy Improves Chemotherapy Effectiveness
Low Doses of an Approved Drug Switches on Pathway that Allows Chemotherapy to Kill Cancer NEW YORK–(ENEWSPF)–August 16, 2013 — Patients with an aggressive lymphoma that often relapses and kills within two years experienced a remission of their cancer and stayed disease-free as long as 28 months after taking a[Read More…]





